Jie Hu
- Cancer Research top 0.5%
- MicroRNA in disease regulation 20
- Cancer-related molecular mechanisms research 11
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 17
- Molecular Biology top 5%
- RNA modifications and cancer 10
- Extracellular vesicles in disease 10
- Immunology top 5%
-
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 10
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jie Hu
127 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 1.8k
- Hepatology 646
- Oncology 989
- Molecular Biology 2.2k
- Immunology 585
Countries citing papers authored by Jie Hu
This map shows the geographic impact of Jie Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Hu more than expected).
Fields of papers citing papers by Jie Hu
This network shows the impact of papers produced by Jie Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Hu. The network helps show where Jie Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 0 | |
| 10 | 2020 | 104 | |
| 11 | 2020 | 43 | |
| 12 | 2019 | 38 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 277 | |
| 15 | 2019 | 84 | |
| 16 | 2018 | 204 | |
| 17 | 2015 | 19 | |
| 18 | 2015 | 28 | |
| 19 | 2013 | 60 | |
| 20 | 2012 | 43 |
About Jie Hu
Jie Hu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 134 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), MicroRNA in disease regulation (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cancer Immunotherapy and Biomarkers (17 papers), Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Extracellular vesicles in disease (10 papers). The work is most often cited by research in Cancer Research (1.8k citations), Hepatology (646 citations) and Oncology (989 citations). Jie Hu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jian Zhou, Jia Fan, Yuanlin Song, Lei Yu, Zhi Dai, Ying Wu, Hongguang Zhu, Jiping Wang, Shaohua Lu and Hui‐Chuan Sun. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.